Skip to main navigation Skip to search Skip to main content

Monoclonal gammopathies of undetermined significance and smoldering myeloma

  • Artur Jurczyszyn
  • , Ruth Hutch
  • , Anna Waszczuk-Gajda
  • , Anna Suska
  • , Katarzyna Krzanowska
  • , David H. Vesole
  • Jagiellonian University Medical College
  • Mid-Western Regional Hospital Limerick
  • Transplantology and Internal Medicine

Research output: Contribution to journal › Review article › peer-review

3 Scopus citations

Abstract

Monoclonal gammopathy of undetermined significance (MGUS) is a clonal plasma cell disorder implicated as a precursor of multiple myeloma (MM), while smoldering multiple myeloma (SMM) is a malignant plasma cell disorder without evidence of a myeloma-defining event(s) (MDE). This is a review article of both disorders outlining their current definition and management according to the current standard of care. We focus on the pathogenesis of MM and the role of MGUS and SMM in the development of active MM. MGUS is a benign disorder and, subsequently, is followed by observation. In contrast, for SMM, although the current standard of care is “watch and wait”, this paper will explore the circumstances in which treatment should be considered to prevent MDE.

Original languageEnglish
Pages (from-to)193-202
Number of pages10
JournalActa Haematologica Polonica
Volume51
Issue number4
DOIs
StatePublished - 1 Dec 2020

Keywords

  • Monoclonal gammopathy of undetermined significance
  • Multiple myeloma
  • Smoldering multiple myeloma

Fingerprint

Dive into the research topics of 'Monoclonal gammopathies of undetermined significance and smoldering myeloma'. Together they form a unique fingerprint.

Cite this